328 related articles for article (PubMed ID: 7370944)
1. Hormonal therapy of prostatic cancer.
Scott WW; Menon M; Walsh PC
Cancer; 1980 Apr; 45(7 Suppl):1929-36. PubMed ID: 7370944
[No Abstract] [Full Text] [Related]
2. Carcinoma of the prostate: early endocrine therapy is best.
Spirnak JP; Resnick MI
Semin Urol; 1983 Nov; 1(4):269-79. PubMed ID: 6399613
[No Abstract] [Full Text] [Related]
3. Physiologic basis for hormonal theapy in carcinoma of the prostate.
Walsh PC
Urol Clin North Am; 1975 Feb; 2(1):125-40. PubMed ID: 48206
[No Abstract] [Full Text] [Related]
4. [The endocrine profile in prostatic cancer: therapeutic implications].
Calvo Mateo MA; Castellanos Llorens JM; Galán Ortega A
Actas Urol Esp; 1981; 5(1):3-12. PubMed ID: 7015803
[No Abstract] [Full Text] [Related]
5. Endocrine therapy for prostate cancer.
Sagalowsky AI
Spec Top Endocrinol Metab; 1985; 7():101-29. PubMed ID: 3914094
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of estrogen-resistant forms of cancer of the prostate].
Marinbakh EB; Ar'e VM
Urol Nefrol (Mosk); 1974; 39(4):68-74. PubMed ID: 4606039
[No Abstract] [Full Text] [Related]
7. Endocrine therapy in the management of prostatic cancer.
Greenberg E
Clin Endocrinol Metab; 1980 Jul; 9(2):369-81. PubMed ID: 6994946
[No Abstract] [Full Text] [Related]
8. [Hormone dependency of prostate cancer].
Suzuki H; Ito H
Nihon Rinsho; 2002 Dec; 60 Suppl 11():59-64. PubMed ID: 12599546
[No Abstract] [Full Text] [Related]
9. Intra-prostatic androgen levels during various androgen-blockade regimens.
Nishiyama T
Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):229-41. PubMed ID: 18471782
[TBL] [Abstract][Full Text] [Related]
10. [Endocrine therapy in late cancer of the prostate].
Momose G
Nihon Naibunpi Gakkai Zasshi; 1965 Dec; 41(9):1069-71. PubMed ID: 5895676
[No Abstract] [Full Text] [Related]
11. Carcinoma of the prostate. Hormonal therapy.
Grayhack JT; Keeler TC; Kozlowski JM
Cancer; 1987 Aug; 60(3 Suppl):589-601. PubMed ID: 3297288
[TBL] [Abstract][Full Text] [Related]
12. New concepts on the androgen sensitivity of prostate cancer.
Labrie F; Luthy I; Veilleux R; Simard J; Bélanger A; Dupont A
Prog Clin Biol Res; 1987; 243A():145-72. PubMed ID: 3309970
[No Abstract] [Full Text] [Related]
13. Total androgen suppression in the management of prostatic cancer. A critical review.
Schroeder FH
Prog Clin Biol Res; 1985; 185A():307-17. PubMed ID: 3898133
[No Abstract] [Full Text] [Related]
14. Castration-resistant prostate cancer--hormone therapy redux.
Tolcher AW; Cooper J
J Clin Oncol; 2010 Mar; 28(9):1447-9. PubMed ID: 20159817
[No Abstract] [Full Text] [Related]
15. The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer.
Nishiyama T; Hashimoto Y; Takahashi K
Clin Cancer Res; 2004 Nov; 10(21):7121-6. PubMed ID: 15534082
[TBL] [Abstract][Full Text] [Related]
16. Hormonal therapy for advanced prostatic carcinoma.
Seftel AD; Spirnak JP; Resnick MI
J Surg Oncol Suppl; 1989; 1():14-20. PubMed ID: 2669792
[TBL] [Abstract][Full Text] [Related]
17. Biologic agents as adjunctive therapy for prostate cancer: a rationale for use with androgen deprivation.
Nelson EC; Cambio AJ; Yang JC; Lara PN; Evans CP
Nat Clin Pract Urol; 2007 Feb; 4(2):82-94. PubMed ID: 17287869
[TBL] [Abstract][Full Text] [Related]
18. Cytology of metastatic prostate cancer following orchiectomy and antiandrogen therapy: a diagnostic challenge.
Rapkiewicz A; Gorokhovsky R; Farcon E; Das K
Diagn Cytopathol; 2008 Jul; 36(7):499-502. PubMed ID: 18528888
[TBL] [Abstract][Full Text] [Related]
19. Endocrine therapy for prostate cancer.
Damber JE
Acta Oncol; 2005; 44(6):605-9. PubMed ID: 16165920
[TBL] [Abstract][Full Text] [Related]
20. [Hormonotherapy for prostate cancer].
Oishi K; Yoshida O
Gan To Kagaku Ryoho; 1993 Dec; 20(15):2300-5. PubMed ID: 8259842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
